hronic liver failure (AOLF). The RELIEFtrial. J Hepatol 2010;52:A1184.Р [7] Kantola T, Koivusalo AM, Parmanen S, H?ckerstedt K,Isoniemi H.Survival predictors in patients treated with a molecularadsorbent recirculating system. World J Gastroenterol 2009;15:3015–24.Р [8]黄春光杨洁飞罗小娟.分子吸附再循环系统治疗肝衰竭患者细胞因子水平变化的应用研究.实验与检验医学,2013,31(2):141-142.Р [9]Novelli G, Annesini MC, Morabito V, et al. Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy. Transplant Proc, 2009,41(4):1243-8.Р [10] Fernandez J, Escorsell A, Zabalza M, et al. Adrenal insufficiency in patientswith cirrhosis and septic shock: effect of treatment with hydrocortisone onsurvival. Hepatology 2006; 44:1288–1295.Р [11]吴赤红,徐小元,陆海英.分子吸附循环系统治疗重型肝炎肝功能衰竭的临床研究.中国急救医学,2004,(10):11-13.
全文预览
